Exact Sciences Molecular Diagnostics GmbH

Exact Sciences Molecular Diagnostics GmbH provides pathological cancer diagnostic services, supplies premises and equipment to pathologists, and performs administrative and other services; the company does not practice medicine. The company operates a laboratory facility in Trier for conducting Oncotype DX Breast Recurrence Score tests with patients in Germany. Exact Sciences Molecular Diagnostics GmbH is a wholly owned subsidiary of Genomic Health/Exact Sciences Corporation and finances its operations through revenues from sales of the Oncotype DX test, with the parent company providing investments when required. The fiscal year corresponds to the calendar year, the subscribed capital is EUR 25,000 and the average number of employees during the financial year was 21 in 2024.